23:54:31 EDT Thu 24 Sep 2020
Enter Symbol
or Name

Login ID:
Microbix Biosystems Inc
Symbol MBX
Shares Issued 108,747,705
Close 2020-04-01 C$ 0.23
Recent Sedar Documents

Microbix Biosystems holders approve AGM resolutions

2020-04-01 17:49 ET - News Release

Mr. Cameron Groome reports


Microbix Biosystems Inc. has released the voting results from the annual and special meeting of shareholders, which was held on March 31, 2020.

At the meeting, 36.79 per cent of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the meeting. Details of all resolutions that were voted upon are set out in the management information circular dated Feb. 14, 2020. The circular is available on the company's website and on SEDAR.

All of the director nominees listed in the circular were re-elected as directors of Microbix. Results of the vote are shown in the attached table.

Nominee                     Votes for  % votes for      Withheld  % withheld

Peter M. Blecher           36,332,546       93.85%     2,378,816       6.15%
William J. Gastle          36,905,352       95.33%     1,806,010       4.67%
Martin Marino              37,024,462       95.64%     1,686,900       4.36%
Joseph D. Renner           37,024,352       95.64%     1,687,010       4.36%
Mark A. Cochran            37,022,462       95.64%     1,688,900       4.36%
Cameron Groome             36,952,854       95.46%     1,758,508       4.54%
Vaughn C. Embro-Pantalony  36,896,452       95.31%     1,814,910       4.69%

In addition, shareholders also approved a resolution reappointing the company's auditor, Ernst & Young LLP, with 99.76 per cent of the votes cast in favour.

In addition, shareholders also approved a resolution ratifying an amendment to the company's bylaws to reduce the quorum requirement for shareholders meetings, with 94.44 per cent of the votes cast in favour.

The slides of management's presentation at the meeting have been posted at the company's website.

About Microbix Biosystems Inc.

Microbix develops proprietary biological and technology solutions for human health and well-being, with sales usually exceeding $1-million per month and approximately 80 skilled employees.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.